Google Is Asking the EPA to Release 32 Million Mosquitoes Across California and Florida to Fight a Dangerous Invasive Species
Alphabet, Google’s parent company, has filed a federal request to release up to 32 million mosquitoes across California and Florida. On instinct, that sounds like the setup to a disaster film. In practice, it’s a formal EPA review process — and the science behind it may be less alarming than the headline suggests.
The central question isn’t whether Google has lost its mind. It’s whether flooding two states with tens of millions of insects could actually reduce the number of dangerous ones.
What Google’s Debug Program Actually Plans to Do
Verily, the life sciences subsidiary of Alphabet, is seeking EPA approval to release up to 32 million male mosquitoes across California and Florida. The insects are infected with Wolbachia, a naturally occurring bacteria that causes reproductive failure when these males mate with wild females. The eggs simply don’t hatch. Over successive generations, the local population of target mosquitoes declines.
Male mosquitoes don’t bite and don’t transmit disease — which makes them safe to release in residential areas without any direct risk to people or pets.
The EPA is currently reviewing Verily’s application. The agency opened a public comment period that ran through June 5, and a final decision timeline hasn’t been announced.
A 60-Year-Old Weapon Against Pests
The sterile insect technique isn’t new technology dressed up in a tech company’s branding. The United States has used it for more than six decades, and the International Atomic Energy Agency formally recognizes it as an environmentally friendly method of pest control.
It has already worked against fruit flies, screwworms, and moths — populations that were either eradicated or severely reduced through sustained releases of sterile males. The track record is long enough to be taken seriously.
Chris Grinter, an entomologist at the California Academy of Sciences, doesn’t mince words. He calls it “a genius technique that has been used to completely eradicate or reduce numbers of serious pests and vectors.” The science is established. What Debug is attempting is an application at scale.
Early Results: Singapore’s Dengue Numbers Tell a Striking Story
Debug hasn’t been waiting for EPA approval to test its methods. Verily ran a smaller California trial in 2017, establishing a domestic proof of concept, and since 2018 the program has been supporting Singapore’s National Environment Agency through Project Wolbachia.
The results from Singapore are difficult to dismiss. According to a May 2026 Debug blog post, the project achieved 80 to 90 percent suppression of Aedes aegypti populations in treated areas. Dengue incidents dropped more than 70 percent after six to twelve months of sustained releases — not marginal improvements, but a meaningful reduction in a disease that hospitalizes and kills people. Singapore’s data gives the California and Florida proposal a real-world benchmark to measure against.
Why Aedes aegypti Is the Target — and Why Its Absence Matters
Not every mosquito species is an appropriate candidate for population suppression. Aedes aegypti happens to be one of the clearest cases. It spreads dengue fever, West Nile virus, malaria, and other fatal diseases to millions of people globally each year. It’s also not native to California or Florida.
That second point carries significant ecological weight. Nathan Burkett-Cadena, an ecologist at the University of Florida, explains the distinction plainly: because the species is non-native, no local wildlife depends on it as a food source. Targeting it avoids the cascading environmental consequences that could follow if a native species were removed from a food web.
The species has also been in conflict with humans for a very long time. A study published in Scientific Reports in February 2026 found that the Anopheles leucosphyrus group of mosquitoes evolved a preference for human blood between 1.6 million and 2.9 million years ago — far earlier than researchers previously believed. The relationship is ancient, and not a friendly one.
The Ethical Debate Scientists Are Not Ignoring
Even a well-supported scientific program can raise legitimate ethical questions. Henry Greely, a bioethicist and law professor at Stanford, has argued that intentionally steering a species toward extinction deserves broad social consensus — not just regulatory approval. “I would want there to be some consideration and reflection,” he has said, “before we take that step.”
That concern is real. Debug’s current approach, though, is population suppression rather than eradication, and experts treat that distinction as meaningful. Reducing a local population isn’t the same as eliminating a species from existence.
Matthew DeGennaro, a neurogeneticist at Florida International University, pushes back from a different angle entirely. He argues that humans are directly responsible for spreading Aedes aegypti across the globe — the mosquito has followed human movement and settlement patterns worldwide. “We have an obligation to control them,” he says. The debate isn’t resolved, and it probably shouldn’t be resolved quickly.
What Comes Next
The EPA’s review is the immediate milestone to watch. If the agency approves Verily’s request, California and Florida would become the largest domestic test of Wolbachia-based mosquito suppression to date. Singapore’s results suggest the method can work at scale. Whether it translates to two very different American ecosystems remains an open question.
Broader issues around public consent, regulation, and long-term ecological monitoring will follow any approval. Debug’s program isn’t the end of this conversation — it may be closer to the beginning.